Page last updated: 2024-10-30

letrozole and Choriocarcinoma

letrozole has been researched along with Choriocarcinoma in 2 studies

Choriocarcinoma: A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Long, BJ1
Tilghman, SL1
Yue, W1
Thiantanawat, A1
Grigoryev, DN1
Brodie, AM1
Mor, G1
Eliza, M1
Song, J1
Wiita, B1
Chen, S1
Naftolin, F1

Other Studies

2 other studies available for letrozole and Choriocarcinoma

ArticleYear
The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
    The Journal of steroid biochemistry and molecular biology, 1998, Volume: 67, Issue:4

    Topics: Anastrozole; Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; Cell

1998
17alpha-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture.
    The Journal of steroid biochemistry and molecular biology, 2001, Volume: 79, Issue:1-5

    Topics: Aromatase; Aromatase Inhibitors; Binding, Competitive; Cell Line; Choriocarcinoma; Dose-Response Rel

2001